Greenspring Associates’s Pulmonx LUNG Stock Holding History

Greenspring Associates’s Portfolio LUNG Stock Details LUNG Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q2	–	Sell	-566	Closed	-$26K	–	15
2021 Q1	$26K	Buy	+566	New	+$32.5K	0.02%	8

Other funds holding LUNG

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return

RTW Investments New York $10B AUM 135.35% 1-Year Est. Return

CIP

Champlain Investment Partners Burlington, Vermont $7.88B AUM 6.82% 1-Year Est. Return

GGHC

Gilder Gagnon Howe & Co New York $8.34B AUM 46.58% 1-Year Est. Return

KXA

KPCB XIII Associates Menlo Park, California $186M AUM 11.23% 1-Year Est. Return

Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return

Greenspring Associates's LUNG Position: Q2 2021 in Review

Greenspring Associates sold out of Pulmonx (LUNG) in Q2 2021, closing a stake of 566 shares — an estimated $26K sold.

Greenspring Associates first reported a position in LUNG in Q1 2021 and held it in 1 quarter. The position peaked at $26K in Q1 2021. 113 funds tracked by Wall St. Rank hold LUNG as of Q2 2021.

Greenspring Associates reported no remaining Pulmonx position as of Q2 2021 after selling out during the quarter.
Greenspring Associates sold 566 Pulmonx shares in Q2 2021, an estimated $26K.
Greenspring Associates first reported a position in Pulmonx in Q1 2021 and held it in 1 quarter.
Greenspring Associates's Pulmonx position peaked at $26K in Q1 2021.
113 funds tracked by Wall St. Rank held Pulmonx as of Q2 2021.

Based on Greenspring Associates's 13F filing for Q2 2021, filed 13 Aug 2021.